Skip to content

Clinical trials

Neurodevelopmental Disorders trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodevelopmental Disorders Country / region: United Kingdom Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20192
20201
20212
20221
20234
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting5
Completed4
Unknown status4
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Longboard Pharmaceuticals3
Brightlobe Limited1
Guy's and St Thomas' NHS Foundation Trust1
Hoffmann-La Roche1
Imperial College London1
John Carroll University1
Neurogene Inc.1
Nottingham University Hospitals NHS Trust1
Royal Devon and Exeter NHS Foundation Trust1
Sussex Community NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodevelopmental Disorders15
Epilepsy5
Autism Spectrum Disorder4
Autistic Disorder3
Seizures3
Attention Deficit Disorder with Hyperactivity2
Epilepsies, Myoclonic2
Intellectual Disability2
Lennox Gastaut Syndrome2
Rett Syndrome2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.